Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma, Large B-Cell, Diffuse
×
acalabrutinib
×
Clear all
Filters
3
NCT04529772
2026-03-31
ESCALADE
Acerta Pharma BV
Phase 3
Active not recruiting
611 enrolled
NCT05820841
2023-08-31
ARCHED
Universität des Saarlandes
Phase 3
Recruiting
330 enrolled